Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders

Abstract

Objective

In this study, it is aimed to determine obsessive compulsive-related disorders (OCRDs) comorbidity among the patients with obsessive compulsive disorder (OCD) and compare patients with OCD with or without comorbid OCRDs in terms of the severity of their OCD symptoms, symptom dimensions, and comorbidity with other axis I disorders.

Methods

The study included 90 patients diagnosed as having OCD according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) diagnostic criteria for OCRDs were used to determine the presence of OCRDs. In order to determine the symptom dimensions and severity of these individuals’ OCD symptoms, we administered the Dimensional Obsessive Compulsive Scale (DOCS) and The Yale-Brown Obsessive Compulsive Scale (Y-BOCS).

Results

In our study, 20% of the patients with OCD simultaneously met the criteria for at least one OCRD, we also found that a significantly greater proportion of this group were men. None of the mentioned disorders was associated with any symptom dimensions we evaluated using DOCS. In addition, no differences were found in the severity of OCD symptoms and comorbid axis I disorders between the group with comorbid OCRDs and the group without comorbid OCRDs.

Discussion

There was no significant relationship between the symptom dimensions of OCD and OCRDs. It is found that OCRD comorbidity does not increase the severity of OCD symptoms and the prevalence of an axis I diagnosis.

Introduction

Obsessive-compulsive disorder (OCD) is characterized by the presence of obsessions, compulsions or both. The American Psychiatric Association (2013) defines obsessions as recurrent, persistent and unwanted thoughts, urges or images that cause marked anxiety and distress, and that individuals try to ignore, suppress or neutralize their obsessions with other thoughts or actions. Compulsions are repetitive behaviors or mental acts that a person feels driven to perform in response to obsessions, performed according to rules that must be strictly obeyed.[1]

According to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), at least one axis I psychological disorder is comorbid in 27–92% of patients with OCD. [25] However, in many studies, life-time comorbidity for OCD ranges between 60% and 90%. [3, 59] The disorders most commonly comorbid with OCD are depressive disorders and anxiety disorders. [38, 10] Common comorbid obsessive–compulsive spectrum disorders with OCD are body dysmorphic disorder (BDD), trichotillomania, skin picking, and tic disorders. [3, 810]

The relationship between OCD and OCD spectrum disorders has been the focus of considerable debate. OCD used to be classified within ‘Anxiety Disorders’ in DSM-IV-TR. [11] In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) published in 2013 by the American Psychiatric Association, OCD is now classified with ‘OCD and Related Disorders’ as a separate diagnostic category. [1] The disorder’s primary symptoms involve repetitive behaviors and a subjective sense of compulsion. OCD and OCD spectrum disorders have common features such as etiology, comorbidity, brain circuits, neurotransmitter abnormalities, family history, hereditary characteristics, and responses to treatment. [12]

Although many studies have debated the relationship between OCD and OCD spectrum disorders, a number of studies have systematically investigated the comorbidity of OCD spectrum disorders in patients with OCD. One of these studies showed that 57.6% of patients with OCD concurrently met the criteria for at least one OCD spectrum disorder and 67.1% had at least one coexistent OCD spectrum disorder in their lifetime history. [13] As a result of the studies that described a relationship between OCD and tic disorder and Tourette’s syndrome [1416], the DSM-5 included a tic-related specifier for OCD. Studies to date have shown that the prevalence of co-occurring BDD is 8.7–14.5% [10, 17, 18], the prevalence of trichotillomania is 5–9% [1921], and the prevalence of skin-picking (excoriation) is 7.8–16.3% [22, 23] for patients with OCD. Relatives of patients with OCD are also frequently diagnosed as having tic disorders, trichotillomania, BDD, hypochondriasis, and other disorders such as eating disorders and nail biting. [16, 20, 24]

Different individuals show a high level of heterogeneity in their symptoms of OCD. [25, 26] Since OCD was first identified, researchers have tried to separate symptoms into homogeneous subtypes. [2732] Each subtype may reflect different underlying psychopathologic processes related to different genetic transition mechanisms and environmental impacts. [33] They may also differ in terms of response to treatment and psychiatric comorbidity [34, 35] and have different neuroimaging symptom profiles. [36, 37] Studies of the symptom dimensions of OCD have found a relationship between the symmetry/order dimension and tics and obsessive-compulsive personality disorder. [29, 38] The hoarding dimension has been described as related to male sex, early onset, impaired social functionality, personality disorders, low response to selective serotonin reuptake inhibitors (SSRI), a high ratio of quitting treatment and to other anxiety disorders. [35] A relationship has been found between female sex and contamination/cleaning dimensions, and between male sex and sexual and religious obsessions. [39] Although patients who respond negatively to SSRI treatment frequently show hoarding/symmetry dimensions and sexual and religious obsessions, their responses vary for cognitive behavioral therapy. [40]

The purposes of this study were to examine obsessive compulsive-related disorders (OCRDs) comorbidity in OCD patients and to compare OCD patients with and without OCD-related disorders in terms of their symptom dimensions and to investigate whether it was more common for patients with OCD-related disorders to have certain obsessions and compulsions. The main hypothesis of this study was that patients with OCD with other OCD-related disorders would frequently have more of certain obsessions and compulsions, and that obsessive-compulsive symptoms tended to be more severe for these patients.

Methods

Sample

Our study sample included 90 consecutive patients aged over 18 years who were admitted to the Ankara Diskapi Yildirim Beyazit Training and Research Hospital Outpatient Service between October 2013 and April 2014. All these patients were newly diagnosed or had been diagnosed earlier as having OCD according to the DSM-IV-TR diagnostic criteria. The study was reviewed and approved by Diskapi Yildirim Beyazit Training and Research Hospital ethics committee. Written consents of the patients were obtained after informing them about the study. Exclusion from the study was based on intellectual disability, cognitive mental disorders, psychotic disorders, bipolar mood disorder, or insufficient education to complete the study tests.

Procedures

Diagnoses of patients included in the study were made using the Structured Clinical Interview Form (SCID-I) for DSM-IV Axis I Disorders. The patients were assessed according to DSM-5 diagnostic criteria for OCD-related disorders. Severity of OCD symptoms was assessed using the Yale-Brown Obsession Compulsion Scale (Y-BOCS). The Dimensional Obsession Compulsion Scale (DOCS) was used to assess the symptom dimensions of OCD.

This group of patients with OCD was examined in terms of their sociodemographic characteristics, comorbidity, severity of OCD symptoms, and symptom dimensions. Patients with a comorbid diagnosis with OCD-related disorders were then compared with patients with no co-occurring diagnoses, using the same parameters.

Measures

Sociodemographic information form.

This form was given to the patients to query their sociodemographic characteristics and the clinical features of their disorder.

The structured clinical interview for DSM-IV axis I disorders.

This is a semi-structured clinical interview tool applied by a trained interviewer in order to investigate axis I psychiatric disorder diagnoses for patients according to DSM-IV. [41] The Turkish validity and reliability study was established by Özkürkçügil et al. [42]

The Yale-Brown Obsessive Compulsive Scale-Y-BOCS.

The Turkish validity and reliability of this scale, which was developed in 1989 by Goodman et al. [43], was established by Karamustafalıoğlu et al. [44] The scale consists of a total of 19 items and is administered by an interviewer. The first 10 items are used to determine the total score. In scoring, each of the subscales of obsession and compulsion has five items and each item is individually scored between 1 and 4. The total score of the subscales for obsession and compulsion provide an overall maximum score of 40.

The Dimensional Obsessive Compulsive Scale (DOCS).

The Dimensional Obsessional Compulsive Scale (DOCS) is a 20-item self-report scale developed by Abramowitz et al. [26] This scale evaluates four distinct obsessive compulsive symptom dimensions; each scale contains general definitions and includes examples of avoidant behavior measures and assesses the severity of each symptom dimension. Thus, the scale provides a link between obsessive, compulsive, and avoidance behaviors in each symptom dimension, and measures the severity of symptoms independently of the types of obsessions and compulsions present. The most frequent identified OCD symptoms in this structural analysis included 1) contamination, 2) responsibility for harm or mistakes, 3) incompleteness, and 4) unacceptable thoughts. Rather than listing the specific indications contained in each dimension, a number of typical thought examples, rituals, and compulsions are presented for each dimension. Within each symptom dimension there are 5 items (to be answered with regard to the prior 30 days), which measure severity according to various parameters. These items are a) time spent with the symptoms, b) avoidance behavior, c) distress experienced, d) impairment/deterioration in functionality, and e) difficulty in coping with the symptoms. The scale is formed from 4 dimensions, each having five items scored between 0 and 4. The Turkish validity and reliability study of this scale was determined by Şafak et al. [45]

Statistical analysis

All data were analyzed by using SPSS Windows version 16.0. Quantitative data are specified as percentages, averages and standard deviations. T-test was used for independent samples to compare normally distributed parameters of two groups. Bonferroni correction was used to determine the value of significance, and the p-value was set as .01 with this correction. On the other hand, two groups were compared on the parameters that were not normally distributed by using the Mann-Whitney U test. Additionally, Pearson’s Chi-square test was used for analyzing relationships between categorical variables. Finally, the significance level was determined as P < .05.

Results

Of the patients included in this study (N = 90), 64 (71.1%) were female and 26 (28.9%) were male. Their ages ranged between 18 and 52 years (mean: 27.4±8.1 years). The distribution of other sociodemographic characteristics of the patients is given in S1 Table.

Twenty-one OCD-related disorders were found in 18 (20%) of the patients. The distribution of these disorders are shown in Table 1.

thumbnail
Table 1. Distribution of disorders related to comorbid obsessive-compulsive disorder.

https://doi.org/10.1371/journal.pone.0218955.t001

Pearson’s Chi-square test was used to compare the distribution of the comorbid OCD-related disorders between the sexes. OCD-related disorders were found significantly more frequently in male patients with OCD (P = .027) (Table 2).

thumbnail
Table 2. Distribution of obsessive-compulsive disorder-related disorders among the sexes.

https://doi.org/10.1371/journal.pone.0218955.t002

The samples’ Y-BOCS and DOCS scores were assessed using a t-test to compare OCD severity levels and symptom dimensions of patients with OCD with and without comorbid OCD-related disorders (Table 3). Bonferroni correction was performed to determine the significance value. No difference was found between the groups in terms of their Y-BOCS and DOCS scores.

thumbnail
Table 3. Comparison of the Y-BOCS and DOCS scores of the patients with and without comorbid OCD-related disorders.

https://doi.org/10.1371/journal.pone.0218955.t003

When the patients were assessed for SCID-I comorbidities according to DSM-IV, no axis I diagnoses were found in 34 (37.8%) patients, and at least one axis I diagnosis was found for 56 (62.2%) patients. Major depression was found in 27 (30%) patients, simple phobias in 10 (11.1%) patients, generalized anxiety disorder (GAD) in 9 (10%) patients, social phobia in 8 (8.8%) patients, panic disorder in 5 (5.6%) patients, and dysthymia in 4 (4.4%) patients.

The patients we studied with OCD-related disorders were also assessed in terms of SCID-I comorbidities according to the DSM-IV. No axis I comorbidity was found in 9 of 18 patients, major depression was found in 8 patients, social phobia in 3 patients, simple phobia in 2 patients, and panic disorder in 1 patient. The patients with and without comorbid OCD-related disorders were compared using Pearson’s Chi-square test in terms of SCID-I comorbidities according to the DSM-IV. No significant difference was observed between the two groups in terms of axis I comorbidities (P = .913) (Table 4).

thumbnail
Table 4. Comparison of the patients with and without obsessive-compulsive disorder-related disorders in terms of axis I comorbidities.

https://doi.org/10.1371/journal.pone.0218955.t004

Discussion

Our study aimed to examine obsessive compulsive-related disorders (OCRDs) comorbidity in OCD patients and to compare OCD patients with and without comorbid OCD-related disorders in terms of symptom severity, comorbidities, and symptom dimensions. We developed two essential hypotheses related to existing scientific data and observations. Our first hypothesis was that some obsessions and compulsions were more frequently found in patients with OCD with certain comorbid disorders specified under OCD-related disorders. The second hypothesis was that obsessive-compulsive symptoms were more severe in these same patients.

When we examined the patients in terms of comorbid OCD-related disorders, we determined that at least one of these disorders was present in 20% of patients. Skin picking disorder was observed in 10%, trichotillomania was found in 5.6%, BDD was found in 4.4%, and hoarding disorder was found in 3.3% of patients. In studies of patients with OCD, the incidence of comorbid trichotillomania varies between 5% and 9% [1921], and the ratio of those with BDD varies between 8.7% and 14.5%. [10, 17, 18] The frequency of trichotillomania found in our study is in agreement with the literature and the rates of comorbid BDD disorder in our patients with OCD were not as high as rates found in other studies. When we take into consideration that a diagnosis of BDD is generally made in patients’ in their mid-thirties, the low rates of BDD ratio found in this study may be associated with the low average age of our study patients. In studies performed to date, hoarding behavior was found in 8.6–40% of patients with OCD. [7, 39] Hoarding behavior causes serious distress in only 5.5% of these patients. The rates specified in these studies were obtained by assessing hoarding as a symptom, not a disorder. In our study, patients were assessed according to the hoarding disorder diagnosis criteria in the DSM-5 and it is found the prevalence of the disorder as 3.3%. A limited number of studies have examined skin picking disorder and a few studies have investigated the symptom under the heading of impulse control disorders. Skin picking occurs in patients with OCD at a rates between 7.8% and 16.3%. [22, 23] The rates found in our study are in agreement with the literature. According to our search, our study is one of the very first studies that investigate the prevalence of DSM-5 OCDRs in patients with OCD.

When we assessed patients with comorbid OCD-related disorders in terms of their sex, the disorders we considered were found significantly more frequently in male patients. In a study by Du Toit et al., 85 patients with OCD were assessed in terms of OCD spectrum disorders (eating disorders, BDD, impulse control disorders and depersonalization disorder) and they found that patients with comorbid spectrum disorders were mostly female. [13] The fact that Du Toit et al. included eating disorders, which are known to be more common in women, may also have caused this difference. Other studies in the literature that considered trichotillomania, skin picking disorder, and BDD have varied more in relation to sex prevalence. [46, 47] Our study cannot fully analyze the relationship between sex and specific OCD-related disorders due to the relatively small sample of such patients. As seen in our study OCRDs are seen frequently in patients who come to the outpatient clinic with OCD symptoms. Therefore, we suggest that it is important to screen OCD-related symptoms in these patients. Since it is found that OCD-related disorders are significantly more frequent in male patients in our study, we think it would be helpful to ask for these diseases without gender difference.

In our study, as Du Toit et al. also found [13], no significant differences were found in severity between patients OCD with and without comorbid OCD-related disorders. This suggests that OCD-related disorders that accompany OCD do not affect the severity of the disorder, and obsessions and compulsions may be independent of these disorders.

Our study showed no relationship between OCD-related disorders and any particular symptom dimensions of OCD. There was no difference in symptom dimensions between the group with OCD only and the group with comorbid OCD-related disorders.

When the patients were assessed in terms of comorbidities, at least one axis I diagnosis was observed in 62.2% of the patients, and major depression was the most frequent comorbid psychiatric disorder at a rate of 30%. These results are generally in agreement with the literature. [28] However, when patients with OCD with and without concomitant OCD-related disorders were compared in terms of their DSM-IV axis I comorbidities, no significant differences were observed between the groups.

Based on the results of our study, when patients with OCD with and without comorbid OCD-related disorders were assessed together, no relationship was evident between the severities of their OCD symptoms. There was no difference in their axis I comorbidity rates and no relationship between their OCD-related disorders and any of several OCD symptom dimensions. This study contributes to the literature in this area, which we expect will be examined further based on the DSM-5.

One of the limitations of our study is that the YBOCS and DOCS scores of treated and newly diagnosed patients with OCD may vary depending on how long they have been treated and whether they show any treatment response. The patients who participated in our study were currently receiving treatment and some were just beginning treatment. The most important limitation of our study is the limited number of patients, which makes it difficult to compare various OCD-related disorders. In larger samples the distribution of symptoms and statistical validity of the analysis would be greater. Based on both these factors, studies with larger samples using a healthy control group are needed.

Supporting information

S1 Table. Distribution of sociodemographic characteristics of the participants.

https://doi.org/10.1371/journal.pone.0218955.s001

(DOCX)

S1 Data. The data collected and used for the study.

https://doi.org/10.1371/journal.pone.0218955.s002

(XLSX)

References

  1. 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington VA: American Psychiatric Association, 2013.
  2. 2. Denys D, Tenney N, Van Megen HJ, de Geus F, Westenberg HG. Axis I and II comorbidity in a large sample of patients with obsessive compulsive disorder. J Affect Disord 2004; 80(2–3), 155–162. pmid:15207928
  3. 3. LaSalle VH, Cromer KR, Nelson KN, Kazuba D, Justement L, Murphy DL. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive–compulsive disorder. Depression Anxiety 2004; 19, 163–173. pmid:15129418
  4. 4. Torres AR, Prince MJ, Bebbington PE, Bhugra D, Brugha TS, Farrell M, et al. Obsessive–compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry 2006; 163, 1978–1985. pmid:17074950
  5. 5. Timpano KR, Rubenstein LM, Murphy DL. Phenomenological features and clinical impact of affective disorders in OCD: a focus on the bipolar disorder and OCD connection. Depress Anxiety. 2012; 29(3):226–233. pmid:22109969
  6. 6. Demet MM, Deveci A, Deniz F, Taskin EO, Simsek E, Yurtsever F. The phenomenology and demographic features of obsessive compulsive disorder. Anatol J psychiatry 2005; 6, 133–144.
  7. 7. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15, 53–63. pmid:18725912
  8. 8. Miguel EC, Ferrao YA, Rosario MC, Mathis MA, Torres AR, Fontenelle LF, et al. The Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders: recruitment, assessment instruments, methods for the development of multicenter collaborative studies and preliminary results. Rev Bras Psiquiatr 2008; 30(3):185–196. pmid:18833417
  9. 9. De Mathis MA, Diniz JB, Hounie AG, Shavitt RG, Fossaluza V, Ferrão YA, et al. Trajectory in obsessive–compulsive disorder comorbidities. Eur Neuropsychopharmacol 2013; 23, 594–601. pmid:22921470
  10. 10. Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, et al. Comorbidity in obsessive–compulsive disorder (OCD): a report from the International College of Obsessive–Compulsive Spectrum Disorders (ICOCS). Compr Psychiatry 2014; 55, 1513–1519. pmid:25011690
  11. 11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington, DC, American Psychiatric Association. 2000.
  12. 12. Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010; 27, 495–506. pmid:20533366
  13. 13. Du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Comparison of obsessive compulsive disorder patients with and without comorbid putative obsessive compulsive spectrum disorders using a structured clinical interview. Compr Psychiatry 2001; 42, 291–300. pmid:11458303
  14. 14. Grad LR, Pelcovitz D, Olson M, Matthews M, Grad GJ. Obsessive compulsive symptomatology in children with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry 1987; 26, 69–73. pmid:3473061
  15. 15. Hasler G, LaSalle-Ricci VH, Ronquillo JG, Crawley SA, Cochran LW, Kazuba D, et al. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res 2005; 135, 121–132. pmid:15893825
  16. 16. Leonard HL, Lenane MC, Swedo SE, Rettew DC, Gershon ES, Rapoport JL. Tics and Tourette’s disorder: A 2 to 7 year follow-up of 54 obsessive compulsive children. Am J Psychiatry 1992; 149, 1244–1251. pmid:1503140
  17. 17. Phillips KA, Gunderson CG, Mallya G, McElroy SL, Carter W. A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry 1998; 59, 568–575. pmid:9862601
  18. 18. Conceição Costa DL, Chagas Assunção M, Arzeno Ferrão Y, Archetti Conrado L, Hajaj Gonzales C., Franklin Fontenelle L, et al. Body dysmorphic disorder in patients with obsessive-compulsive disorder: prevalence and clinical correlates. Depress Anxiety 2012; 29, 966–975. pmid:22815241
  19. 19. Stewart SE, Jenike MA, Keuthen NJ. Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications. J Clin Psychiatry 2005; 66, 864–869. pmid:16013902
  20. 20. Browne HA, Gair SL, Scharf JM, Grice DE. Genetics of obsessive-compulsive disorder and related disorders. Psychiatr Clin North Am 2014; 37(3), 319–335. pmid:25150565
  21. 21. Matsunaga H, Kiriige N, Matsui T, Oya K, Okino K, Stein DJ. Impulsive disorders in Japanese adult patients with obsessive-compulsive disorder. Comp Psychiatry 2005; 46, 43–49.
  22. 22. Grant JE, Mancebo MC, Pinto A, Eisen JL., Rasmussen SA. Impulse control disorders in adults with obsessive compulsive disorder. J Psychiatr Res 2006; 40, 494–501. pmid:16430922
  23. 23. Lovato L, Ferrão YA, Stein DJ, Shavitt RG, Fontenelle LF, Vivan A, et al. Skin picking and trichotillomania in adults with obsessive-compulsive disorder. Comp Psychiatry 2012; 53, 562–568.
  24. 24. Rapaport JL, Inoff-Germain G. Treatment of obsessive compulsive disorder in children and adolescents. J Child Psychol Psyciatry 2000; 41, 419–431.
  25. 25. McKay D, Abramowitz JS, Calamari JE, Kyrios M, Radomsky A, Sookman D, et al. A critical evaluation of obsessive-compulsive disorder subtypes: Symptoms versus mechanisms. Clin Psychol Rev 2004; 24, 283–313. pmid:15245833
  26. 26. Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, et al. Assessment of obsessive-compulsive symptom dimensions: Development and evaluation of the dimensional obsessive-compulsive scale. Psychol Assess 2010; 22, 180–198. pmid:20230164
  27. 27. Hodgson RJ, Rachman S. Obsessional-compulsive complaints. Behav Res Ther 1977; 15, 389–395. pmid:612339
  28. 28. Sanavio E. Obsessions and compulsions: The Padua Inventory. Behav Res Ther 1988; 26, 169–177. pmid:3365207
  29. 29. Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, et al. Symptoms of obsessive-compulsive disorder. Am J Psychiat 1997; 154, 911–917. pmid:9210740
  30. 30. Calamari JE, Wiegartz PS, Janeck AS. Obsessive-compulsive disorder subgroups: a symptom-based clustering approach. Behav Res Ther 1999; 37, 113–125. pmid:9990743
  31. 31. Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry 2008; 165, 1532–1542. pmid:18923068
  32. 32. Abramowitz JS, Franklin ME, Schwartz SA, Furr JM. Symptom presentation and outcome of cognitive-behavioral therapy for obsessive-compulsive disorder. J Consult Clin Psychol 2003; 71, 1049–1057. pmid:14622080
  33. 33. Katerberg H, Delucchi KL, Stewart SE, Lochner C, Denys DA, Stack DE, et al. Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet 2010; 40, 505–517. pmid:20361247
  34. 34. Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, et al. Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study. Am J Psychiatry 2002; 159, 263–268. pmid:11823269
  35. 35. Samuels J, Bienvenu OJ, Riddle MA, Cullen BA, Grados MA, Liang KY, et al. Hoarding in obsessive compulsive disorder: results from a case-control study. Behav Res Ther 2002; 40, 517–528. pmid:12043707
  36. 36. Van den Heuvel OA, Veltman DJ, Groenewegen HJ, Dolan RJ, Cath DC, Boellaard R, et al. Amygdala activity in obsessive-compulsive disorder with contamination fear: a study with oxygen-15 water positron emission tomography. Psychiatry Res 2004; 132, 225–237. pmid:15664794
  37. 37. Rauch SL, Wedig MM, Wright CI, Martis B, McMullin KG, Shin LM, et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007; 61, 330–336. pmid:16497278
  38. 38. Baer L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 1994; 55, 18–23.
  39. 39. Li Y, Marques L, Hinton DE, Wang Y, Xiao ZP. Symptom dimensions in Chinese patients with obsessive-compulsive disorder. CNS Neurosci Ther 2009; 15, 276–282. pmid:19691547
  40. 40. Alonso P, Menchon JM, Pifarre J, Mataix-Cols D, Torres L, Salgado P, et al. Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. J Clin Psychiatry 2001; 62, 535–540. pmid:11488364
  41. 41. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis 1 Disorders, Clinical Version (SCID/CV). Washington, DC: American Psychiatric Association. 1997.
  42. 42. Özkürkçügil A, Aydemir Ö, Yıldız M, Danacı AE, Köroğlu E. DSM-IV Eksen I Bozuklukları için Yapılandırılmış Klinik Görüşmenin Türkçe’ye uyarlanması ve güvenilirlik çalışması. İlaç ve Tedavi Dergisi 1999; 12, 233–236.
  43. 43. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale, I: Development, use and reliability. Arch Gen Psychiatry 1989; 46, 1006–1011. pmid:2684084
  44. 44. Karamustafalıoğlu KO, Üçisik AM, Ulusoy M, Erkmen H. Yale-Brown obsesyon kompulsiyon derecelendirme ölçeğinin geçerlilik ve güvenilirlik çalışması. 29. Ulusal Psikiyatri Kongresi Program ve Bildiri Özetleri Kitabı, Bursa. Savaş Ofset, 1993, p:86.
  45. 45. Şafak Y, Say D, Özdel K, Kuru E, Örsel S. Dimensional approach to obsessive-compulsive disorder: Dimensional obsessive-compulsive scale with Turkish psychometrics. Turkish J Psychiatry 2018;
  46. 46. Flessner CA, Busch AM, Heideman PW, Woods DW. Acceptance-enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif 2009; 32, 579–594.
  47. 47. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics 2005; 46, 317–325. pmid:16000674